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A possible association of Borrelia bJlrgdOljeri with lo-
calized scleroderma is currently the focus of intense 
research and discussion. Skin biopsies from 30 pa-
tients with localized scleroderma (28 of the plaque 
type/morphea; two linear scleroderma) were ana-
lyzed for the presence of BOI'l'elia bllrgdOljeri using 
three different polymerase chain reaction systems for 
amplification of segments of borrelial genes. 
Formalin-fixed, paraffin-embedded biopsies of 14 
patients and fresh-frozen, cryo-conserved biopsies of 
16 patients with localized scleroderma were ob-
tained. Lesions of all patients showed clear signs of 
scleroderma and disease progression at the time of 
biopsy. Fresh-frozen as well as formalin-fixed biop-
sies from patients with erythema migrans or acroder-
matitis chronic a atrophicans were used as positive 
controls. 
I n recent years , several studies analyzin g a possible associa-tion of BOlTe/in b"rgdOljeri (Bb) with loca lized sclerode rma (LS) based on serologic methods [1- 8] , bacterial culturc [6 ,9-11 ], immunohistochen~ica l [6, 12], or molecular anal-ys is [1 3-1 5] have been pubbshed . However, th ese studies, 
in total, did not lead to unequivocal results . Several studies found 
elevated titers of serum an tibodies to Bb in 30-46% of patients with 
LS [1-3]. others in only a few or no patients with LS [4-6] . Bb- Like 
spirochetes have been isolated from at least four patients with LS: 
one patien t with lesions resembling acrodcmlatitis chronica 
atrophicans (ACA) [9], two patients with LS, one of them with 
atrophodermia Pastni and Pierini [10], and a furth er patient with 
atrophodennia Pasini and Pierini [11]. 
To further e lucidate a possible association of Bb with LS, lesions 
o f 30 patients with LS w ere analyzed using the highly sensitivc 
polym erase chain reaction (PCR) technique. To increase the 
ovcrall sensitivi ty, three difl:e rent nested PC R assays for amplifica-
tion of differen t chromosomal genes of Bb were used upon each 
sampl e. T hcse sys tems had previously been shown to detect at least 
three major subtypcs of Bb. 
T he first PC R system, originaJl y dcsigned for the detection and 
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With all three polymerase chain reaction systems, 
borrelial DNA was detected in none of the 30 speci-
mens of localized scleroderma. In contrast, with one 
polymerase chain reaction system, BOI'Yelia bllrgdoifel1--
specific DNA was found in 24 of 27 frozen biopsies 
from patients with erythema migrans and in all 5 
analyzed frozen biopsies of patients with acroderma-
titis chronica atrophicans. In approximately half of 
the paraffin-embedded biopsies from patients with 
erythema migrans (nine of 23) and acrodermatitis 
chronica atrophicans (13 of 27), BOI'Yelia bl/l'gdOljed-
specific DNA was identified. 
These results question the association of localized 
scleroderma with known subtypes of Borrelia bJtrgdol'-
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subtyping of Bb in paraffin-cmbedded tissuc [16,17], amplified a 
short segm cnt of a ch rom osomal gene of Bb [18,19]. Nucleotide 
sequence analysis and hybridization with an internal oligonucleo-
tide probe had been perform ed in a representative nWllber of cases, 
confirming the specificity of the pe R products [1 6]. In a second 
p e R system , a segm ent of the borrelial Ragellin gene [20] was 
amplified. Primers were designed to anneal to regions conserved 
between different bo rre ljal sp ecies to increase the chances fo r 
additional detection of spirochetes other than Bb. T he third PCR 
system amplifies a relatively large segm ent of the Ragellin gene 
[1 4,2 1] . 
In all three sys tem s, specificity was assessed by the ana.lysis of 
DNA from diffe rent subtypes of Bb or other spirochetes, phyloge-
netica lly near or f.1r rclated to Bb. [n addition, positivc control 
reactions with DNA from skin biopsies of patients with erythem a 
mig rallS (EM) or ACA were perfornl ed. As III tern a.l positive 
controls , indicatin g tha t DNA of sufficient quality and quantity was 
obtai.ned, a 207-bp fragment of the human bcta-actin gene [16, 22] 
was amplified. 
MATERJALS A ND METHODS 
Patients and Specin,ens Specimens of 28 patients with morphea of the 
p laq ue type (22 fema le, six male) and two fe male patien ts with linear 
scleroderma were analyzed . Lesions were biopsied wi thin the marginal 
e rythematous area (lilac ring) and were either fresh- frozen and cryo-
conserved (16 specimens) o r forma lin-fixed anC! paraffin-embedded (14 
specimcns). At the time of biopsy all patients had cl inicaUy progressive 
disease with new inflammatory lesions. Duration of symptoms was less than 
1 year in seve n patients, 1-5 YC;lTS in nine patie nts, 6 -1 0 yea rs in seven 
patients, and no t clearly rem embered by the patient in the remaining seven 
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cases. In 13 patients only the trunk, in five patients only the extremities, and 
in 12 patients the trunk and extremities were affected. In 11. patients, from 
w hom fresh-frozen biopsies were taken, antibiotic treatment had been 
performed in the past (ill six patients 4-6 months ago, in 5 patients 1-3 
years ago). Biopsies from all other patients had been obtained before 
administration of any antibiotic treatment. 
As positive controls, DNA of biopsies liom pati ents with EM (27 
fresh-frozen, 23 formalin-fixed) or ACA (five fresh-frozen, 27 formalin-
fixed) were used. As negative control s, DNA from normal skin or from 
patients with lesions not related to Bb (T-ce ll lymphoma, lupus erythema-
tosus) were used. 
IgM and IgG serum antibodies to Bb had been evaluated in 18 patients 
with LS by an indirect immunofluorescence assay. T he sera were preab-
sorbed fo r 'cross-reactive' antibodies with a TrepO//CIJ1a pltngcdcJlis ul tl'asoni-
cate. IgM or IgG antibody titers at leas t 1:10 were regarded as eleva ted (23). 
Resu lts were confirmed by a Bb flagellum enzyme-linked immunosorbent 
assay (24). In one patient with LS, IgM antibodies (1 :10) , in an' other patient 
IgG antibodies (1 :64), and in two patients IgM and IgG antibodies (1 :10; 
1 :80 and 1:1 0; 1 :20) were found to be elevated. 
Cultured Strains of Borrelia bllrgtloiferi DN A isolated fro m straIns 
belonging to three different subtypes of Bb were used: Bb sensu stri cto 
(strains B3 1, Ipl , 225), Borrelia gariJlii (stra ins N34, Ho lA, 20047) and the 
VS 461 group of Bb (strains ECM 1, B023). As specificity contro ls, strains of 
Bon'clia parkeri, Borrelia I. •.• ricn tae, and BO'l'clia ir el'll. sii were used [25). T hese 
borre l.i ;l l strains are known to ca use relapsing fever not related to Lyme 
disease in humans. All bon'e1ia l strains were kindl y obta ined rrom Dr. 
Gobel, Freiburg, Germany. As further controls, strains of Trepo llelll a pal/itllllll 
(American Type C ul ture Collection 27087), the causative agent of syphil; s, 
as we/J as Trepollelll a delll.ico/a (American Type C ulture Co/J ection 33520), 
which belongs to the normal bactcria l flora of the ora l cavity, were used . 
DNA Isolation Fresh-frozen biopsies were cut into sma ll pieces and 
transferred into 1.65-m l m;crocentrifuge tubes and digcsted with 1 mg/ml 
Proteinase K (Boeh~nger, Mannheim) in buffer (0.2 M T ri sCl, pI-! 8.0, 
10 mM ethylenediamin etetraacctic acid , 1 'X, sodium dodecylsulfate). After 
incubation at 55°C for 2 d, DNA was extracted by phenol/chloroform , 
ethanol precip itated, and redissolved in 100 /1,/ of destill ed and autoclaved 
water. DNA iso lation from fo rmalin-fixed, parafrin-embedded tissue was 
performed as described [26,27J. Briefly, ten 15-/1m-thkk ti ssue sections 
were cut fro l11 each block. To avoid cross contamination, the blade of the 
microtome was changed between samples. T he sections were dcparaffi ,"ized 
by xylene, pelleted by centrifllgation and resll spended in bufte r with 
Proteinase K (1 mg/ml) and processed as describcd above. DNA isolatio n 
fi'om bacteri al cultures was performed by pelleting the heat-inactivated 
stra ins and resuspension in digestion bu fte r with Proteinase K, fo llowed by 
DNA extraction as described above. 
peR Amplification Reactions T hree different nested PCR systems for 
amp l.i fication of segm ents of borrdial gcnes were used. Ten microli ters of 
thc DNA solution of each sample werc used as template for PCR 
3mpl;fica tion re'lctions in a final volume of 50 /11 containing a PC R reaction 
mixture as described [1 6,27]' In a first round , 30 or 40 cycles ofPCR using 
an outer primer pair were performed . Subsequently, an aliquot ofthc PCR 
reaction (0.5 /11) was used as templ ate for an additional 30 rounds of PCR 
using an ;nner primer pair. Ten microliters of the fma l product were 
ana lyzed by non-den'lturing agarose gel electrophores is (2.5% agarose in 
Tris-borate-EDTA) and visualized by ultravio let rad iation after e thid ium 
bromide staining. 
T he first PCR system was designed to detect Bb in paraffin-embedded 
tissue. For this purpose, a re latively short gene segm ent is targeted and 
amp li fied by PC R. 11 6). In a first round , H 171-bp segment of a chromosomal 
gene of Bb [18 ,19) was amplified by 30 cycles of PCI'!.... Subsequently, an 
aliquot of the PCR product was used as a template for an add itiona l 30 
cycles ofPCR ampli fying a 92-bp inner fragment of the fi rst PCR product. 
Primer sequences and amplification conditions were as described [1 6J. 
The second PCR system was designed to detect Bb as well as o th er 
unknown possible borre l; al species. For this purpose, o ligonucleotides for 
PC I'!... were designed to be complementary to a region of the flagellin gene 
high.l y conserved between vario us borrelial specimens 120). A 194-bp 
fragmcnt of the flage ll.in gene was amplificd by 30 cycles with an outer 
primer pa ir fo llowed by nested PC R amp li fi cation of a 164-bp inner 
fragment by additional 30 cycles . Annea ling temper;ltures were 51°C. O uter 
primer sequences were 5' GAA GCG ATT GCT GTA AAT ATT TAT 3' 
and 5 ' TTA GCA TCA A T GTG GTT GTA ACA ITA A 3'. Inner 
primcr sequences were 5' AAT ATT TAT GCA GCT AAT GTT GCA AA 
3' and 5' GGT TGT AAC ATT AAC AGG AGA ATT AA C 3' . 
In " third PCR system, a 730-bp Ii·agment of the borre li al flage llin gene 
(28) was amplifi ed , fo llowed by nested PCR amplifi cation ofa 290-bp inner 
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fi·agmcnt. Primer sequences and amplification conditions were as described 
[14 ,21). 
In addition , a 207-bp fi'agm cnt of the human beta-actin gene was 
;l mplified to ascertain isolation of DNA of suffi cient quality and quantity 
from all analyzed clinical spec im ens. Primer sequences and amplifi cation 
conditions were used as described [1 6]. 
RESULTS 
T he specifi city of PCR prime rs of all thrce system s was tested using 
DNA from c ulturcd strains of the th t·ee known sub typ es of Bb (Bb 
sensu stricto, Borrelia garillii, and the VS 461 gro up of Bu) and of 
spiroc hetes not relate d to Lyme borreli osis (Borrelia !tenllsii, parkeri, 
fll ricalae, and Trepollellla pallidlllll and dellficola) . All three P CR 
systems did not yield any specific produc ts ii'om D N A £i·om 
T reponema paI/itllllll and del/ficola but amplifi ed DNA fro m all threc 
subtypes of Bu. In addition, t he second P C R system amplifie d DNA 
from Bon·elia herlllsii, parkeri, and Illricalae and thc third P C R system 
amplified D N A £i·om Borrelia !tenllsii. The first PCR sys tcm , being 
most specific for dctection of DNA fro m Bb, did not ampli fy DNA 
from any other strains. 
With the first PCR system, Bb was detected in non e of 3 0 
biopsics o f p atie n ts w ith LS, but in 24 o f 27 analyzed fres h -fi·ozen 
biopsies of pati ents w ith EM and all five analyzed fi·cs h-frozen 
b iopsies of pati ents w ith ACA (Fig 1). In add it ion, Bb w as detected 
in nine of 23 form alin-fixe d biopsies o f pa t ients with EM and in 13 
of 27 form alin-fixed biopsies of patie nts w ith ACA. 
Using the second PCR system, Bb was detecte d in none of 30 
biopsies of patients w ith LS, but in 16 of 21 fj'esh-froze n biopsies of 
p aticnts w ith EM and all five ,1Ilalyzcd fresh-frozen bi opsies of 
patients wi th ACA . In formalin-fIXed t issue, Bu was detected in two 
of 12 patients w ith EM. 
Using t he thi rd PCR sys te m , Bu-specific DNA 'was detected in 
n o ne of30 biopsies of patients w ith LS, bu t in l1 of21 fi·esh- frozen 
bio psics of paticnts w ith EM and two of fiv e an a lyzed fi·csh-froze n 
biopsies of patients w ith ACA. In forma lin- fi xed tissue, Bu was 
detected in o n e of 12 patients w ith EM. Positive contro l reactions, 
ampl ifYing a segm ent of the human be ta-actin genc, w e re p ositive 
in a ll clinical samplcs. 
DISC USSION 
In this stud y, in none of the 30 biopsy specim en s of patie n ts with LS 
borrelial D NA was detected usin g three diffe rent PCR system s. T he 
isola tion of D NA suitab le for P C R amplifi ca tion was d e m o n strate d 
in all specime n s by amplifica tion ofa 207-bp fragm ent of th e human 
beta-ac tin gene. 
To validate the PCR system s used, special emphas is was put on 
exte n sive n ega tive ,1l1d positive control expe rim e nts in cl uding 
studies for determination of the specificity of the th ree systems 
used. None of the PCR sys te m s a mplified DNA from sp iroch etes 
n ot closely re late d to Bb, sllc h as Trepo ll ema pallidlllll and Trepo ll elll a 
delllicola . Onl y the first PCR system prove d to be hig hl y specifi c for 
detectio n of Bli and did n ot react with an y other tested bon·e1ial 
strains. In additio n to studics o n LS, as reported he re, w e are 
curre ntly using this system for rou tine assessm ent of specim e ns of 
patients w ith atyp ica l manifesta tions of EM 0 1· ACA [16) . T he 
second primer set was d esig ned to be con side rably more non-
specific, to in crease the c hances for d e tection of any bo n 'e1 ia l DNA 
in les ions of LS . However, e ven using thi s system , b OlTelial DNA 
was n o t detected in any of the 30 analyzed cascs of LS. T he third 
PCR system , usin g conditions as describe d (1 4) , amplifi e d DNA 
from Bil and Borreli~ "'en ll s ii , but, in o ur study, did not dctcct DNA 
from any of th c 30 cases of LS . 
A s posit ive control rcactions, DNA fro m lesions of EM and ACA 
w ere a mplifi ed w ith a ll three PCR systems. U sin g thc firs t systcm, 
whi c h a mplifi es thc shortest D N A fra g m ent (171 bp/92 bp) as 
compa re d to the oth er two system s, BIi-specifi c DNA was d e tecte d 
in the vast m ajor.ity of fi'esh-froze n biopsi es of EM and ACA and in 
less than ha lf of formaljn-fi xed, paraffin-embcdde d cases of EM and 
ACA. T hese d ata indicatc that this system is a bl c to detect Bli in 
cl inica l specime ns with a rclatively hig h sen sit ivity, at least in 
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Figure 1. Rep~esentative analysis of Skill biopsies for the pre sence o f B OI'I'e/ia blll'gdOJjcli - sp ecific DNA; A segm ent of a chromosomal gene of 
Borre/ia IJllrgdOljen spcclflc gene was arnpb fi ed by nested pe R (fi rst system , sec text). Lalle M, PhiX 174 D N A digested with H ac III as molecular size marker. 
Latles 1-5, loca li zed scleroderma; lalles 6 - 10, erythema migrans ; lalles 11-12, acrodermatitis chronica atrophican s; lalle 13, gran u.l orna ann ulare; lalle 14, 
negative contro l (no DNA). A clear amplificatio n product is seen inlalles 6-12 (erythem a migrans and acroderm atitis chronica atrophicans) . No am plification 
product is seen in lallcs 1-5 (loca li zed scleroderma). 
fi'es h-frozen bio psies. U sing the third sys tem , we were not able to 
detect borreli al D NA in more than 1.1 o f 21 fresh-frozen biopsies of 
EM and tw o of fi ve fresh- frozen specimens of ACA or in more than 
one of 12 fo rm alin- fi xed specimens of EM. W ith tlus system , a 
rela tively Jarge fi'agment ofb orrelial DNA is ampli fied (730 bp1290 
bp) . In o ur experience, as well as that of other groups [26,29], 
amplifi cation o f such large fi agments is severely hampered in D NA 
from fo rmalin-fixe d , paraffi n-embedded tissue because of extensive 
degntda tion of D NA during the process of fi xation in fo rmalin . In 
contrast to a recently published study, which detected bo rrelial 
DNA in all analyzed (nine of tune) formalin-fixed , p ara ffin-
embedded lesions o f patien ts wi th LS using tlu s system [14] , we 
were no t successful in ampli fica tion of Bb-speci fic DNA in fo rma-
lin-fixed, as wen as fj'esh-frozen, biopsies of patients wi th LS. 
O ur data do not support the concept of the presence of Bb in 
ac tive lesion s ofLS. T hey do not excl ude that Bb may be presen t in 
a subset of patients with early scle ro tic lesions, ini tiating a disease 
process with connective tissue reactions similar or iden tica l to 
scleroderma. O ur data also do not entirely excl ude the possibili ty of 
an association ofLS with unknown spirochetes related to Bb or with 
unknown subtypes of Bb, which are not detected by the PCR 
system s used . Analogously, in studies reporting the molecul ar 
detection in Bb in lesions of LS and lacking extensive specificity 
controls fo r tlle PC R systems used , the possibili ty of the detection 
of spirochetes not identica l to Bb cannot be excluded . 
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ANNOUNCEMENT 
The Second Seou l International Dermatology Symposium wiJl be he ld May 11-14, 1995 in 
Seoul, Korea. A Post-Congress M eeting will be held May 15-19, 1995 in Beijing, China. 
T h.i s symposium is sponsored by the Departments of D ermatology, Y onsei University 
CoUege of M edicine, Seou l, Korea and the J efferson Cente r for International Dermatology, 
T homas Jefferson University, Jefferson Medical College, Ph.iladelphia, PA. For furth er 
information, please contact Eileen O'Shaughnessy, Meeting Coordinator, J C ID, J efferson 
Medical College, 233 S. 10th Street, Suite 450 BLSB, Phjladelphia, PA. Tel. (215) 955-5785; 
FAX (215) 955-5788 . 
